UBS has set the clock ticking on a batch of exchange-traded notes, telling investors that all outstanding securities across ten ETN series listed on NYSE Arca will be called in. The final trading sessions are staggered: holders of HDLB, PFFL and SMHB face a last day of 16 December, while the remaining seven series are scheduled to stop trading on 17 December. Every outstanding security in each affected series is covered by the redemption.
The announcement landed a day after the stock closed at €43.80, down 1.9%. It also follows a separate notice from UBS Investment Bank on 5 November covering coupon payments on five ETRACS ETNs on NYSE Arca and expected coupons for three more ETRACS notes on Nasdaq.
Third-Quarter Profit and Asia Momentum
Away from the note book, the group’s third-quarter 2026 results showed net profit of USD 2.69 billion and a CET1 capital ratio of 14.7%. The Asia-Pacific region contributed USD 18 billion in net new assets, and the wealth management business there posted a record pre-tax profit — a regional bright spot tucked inside the broader earnings release.
Property Gauge Cools as Fund Fills Up
Support for the investment case has also come from the Swiss property side. UBS’s Swiss Real Estate Bubble Index eased to 0.64 points from 0.71, though the bank kept its classification of bubble risk at “moderate” for the third quarter of 2026 — a move pointing toward less overheating risk rather than a change in category.
Demand for the bank’s property products looks solid as well. The UBS Direct Mixed Urban real estate fund wrapped up its capital increase on 4 November, with every new unit subscribed and roughly CHF 183 million flowing into the vehicle.
Should investors sell immediately? Or is it worth buying UBS?
Capital Rules Loom Larger Than Bricks
How much weight these property signals carry depends on the regulatory arithmetic. Under a mooted compromise on UBS’s own funds requirements, more conservative valuations of foreign subsidiaries could shrink the extra capital the bank would need to hold. Bloomberg reported that the size of any relief remained unclear.
That leaves investors weighing two forces pulling in opposite directions: a property business offering steadier arguments, and a capital question that could ultimately dominate the picture. A cheaper valuation would look more convincing if both moved the same way.
London Cuts Keep Cost Question Alive
Caution is also warranted on the operational front. Bloomberg reported on 5 November that around 200 roles were being cut in London across several areas, including wealth management and investment banking, with some staff offered internal transfers. UBS declined to comment. Whether such measures genuinely improve the cost base while keeping the affected businesses competitive is the test that matters.
The next real catalyst is clarity on the own-funds model — the point at which the market will learn whether the mooted relief becomes a durable argument for shareholders.
Ad
UBS Stock: Buy or Sell?! New UBS Analysis from November 13 delivers the answer:
The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 13.
UBS: Buy or sell? Read more here...
